Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rocuronium and nitroglycerin on pain during intravenous regional anesthesia
IRCT20141209020258N183Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rocuronium and nitroglycerin in Forearm Fracture, sponsored by Arak University of Medical Sciences. Primary endpoint: Pain intensity during intravenous regional anesthesia. Started Jun 2023; status: completed.
02
Drugs
rocuroniumnitroglycerin
03
Conditions
Forearm Fracture
Beyond the preview
Go deeper on IRCT20141209020258N183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N183.